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ABSTRACT 
 
Biomolecular logic systems processing biochemical input signals and producing “digital” outputs 
in the form of YES/NO were developed for analysis of physiological conditions characteristic of 
liver injury, soft tissue injury and abdominal trauma. Injury biomarkers were used as input 
signals for activating the logic systems. Their normal physiological concentrations were defined 
as logic-0 level, while their pathologically elevated concentrations were defined as logic-1 
values. Since the input concentrations applied as logic 0 and 1 values were not sufficiently 
different, the output signals being at low and high values (0, 1 outputs) were separated with a 
short gap making their discrimination difficult. Coupled enzymatic reactions functioning as a 
biomolecular signal processing system with a built-in filter property were developed. The filter 
process involves a partial back-conversion of the optical-output-signal-yielding product, but only 
at its low concentrations, thus allowing the proper discrimination between 0 and 1 output values. 
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INTRODUCTION 
 
Chemical1-5 and biochemical6-10 systems mimicking Boolean logic gates and their networks have 
recently been designed for novel computational and signal processing applications. Particularly 
rapid development has been achieved for biomolecular systems including those based on 
proteins/enzymes,10,11 DNA,9,12 RNA13 and whole cells.14,15 Specifically, it has been realized that 
operation of biomolecular computing systems in biochemical and particularly biological 
environments16 enables design of novel biosensors capable to multiplex and logically process 
many biochemical signals in the binary format 0 and 1, with the information processing steps 
carried out by chemical systems rather than electronics.17 Several biomolecular logic systems 
have been designed for biomedical/diagnostic applications aiming at the analysis of biomarkers 
characteristic of various diseases18-20 or injuries.21-25  
 
A major difference between such systems operating as multi-signal processing biosensors and 
those designed for (bio)chemical computing is in the definition of 0 and 1 levels of input signals. 
For chemical computing, logic-0 can be selected as the absence of a reacting species and logic-1 
defined at a conveniently high concentration of that species. In the systems designed for the logic 
analysis of biomedical conditions, logic-0 and 1 should correspond instead to normal 
physiological and pathophysiological conditions, respectively. In some digitally operating 
biosensor systems the answer YES/NO is easily achieved due to a large difference in the 
biomarker concentrations (e.g., in the pregnancy tests). However, in many cases the difference 
between 0 and 1 inputs is not very large, potentially resulting in a small gap separating the output 
signals. This makes differentiation of the YES/NO answers of the binary biosensing systems 
difficult, unless careful optimization is performed.26  
 
This problem can be partially solved by optimization of the readout time, getting the signals at 
the time when they are substantially different due to different kinetics in the reacting 
processes.21,23 However, if chemical output signals are to be used for triggering chemical 
actuators, for example a drug releasing membrane,27 this approach cannot be utilized because the 
product concentrations for the YES/NO results could reach the same levels at different reaction 
times. The problem of the output signal discrimination can be solved by application of chemical-
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filter component processes converting convex response function characteristic of most chemical 
processes, to sigmoidal.28 These novel chemical filter systems were recently designed and 
optimized as standalone elements of logic networks.29,30 The present Letter describes the first 
application of a filter system for enabling the desired binary, here AND, function, and improving 
the fidelity of signal conversion in biomedical analytical systems exemplified by logic systems 
for the analysis of liver injury (LI), soft tissue injury (STI) and abdominal trauma (ABT), which 
were recently designed23 and then tested for robust operation in human serum solutions.21 
  
 
EXPERIMENTAL SECTION 
 
Chemicals and reagents used:  For the LI system, alanine transaminase (ALT) from porcine 
heart (E.C. 2.6.1.2), lactate dehydrogenase (LDH) from porcine heart (E.C. 1.1.1.27), 
glucose-6-phosphate dehydrogenase (G6PDH) from Leuconostoc mesenteroides (E.C. 1.1.1.49), 
β-nicotinamide adenine dinucleotide reduced dipotassium salt (NADH), L-alanine (Ala), 
D-glucose-6 phosphate (Glc6P), α-ketoglutaric acid (α-KTG), tris(hydroxymethyl)-
aminomethane (Tris-buffer), and other standard inorganic/organic reactants were purchased from 
Sigma-Aldrich and used as supplied. Ultrapure water (18.2 MΩ·cm) from NANOpure Diamond 
(Barnstead) source was used in all of the experiments. Composition and results for logic systems 
for the analysis of STI and ABT operated in buffer solutions, as well as for the LI system 
operated in human serum, are presented in Supporting Information, were the chemicals used for 
the STI and ABT systems are specified. 
  
Instrumentation and measurements:  A Shimadzu UV-2450 UV-Vis spectrophotometer, with a 
TCC-240A temperature-controlled holder and 1 mL poly(methyl methacrylate) (PMMA) 
cuvettes, were used for all optical measurements. All optical measurements were performed in 
temperature-controlled cuvettes at 37.0 ± 0.2˚C mimicking physiological conditions, and all 
reagents were incubated at this temperature prior to measurements. In order to facilitate the 
signal-conversion quality analysis assessing the analytical variance present (as described later), 
four repeated experiments were performed for each of the four input combinations, with and 
without the signal filtering process. 
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Composition and operation of systems for the analysis of injury:  The LI analyzing system was 
realized in the Tris-buffer, 100 mM, pH 7.4, used as a background solution. Ala (200 mM), 
α-KTG (10 mM) and NADH (300 µM) were dissolved in this solution to perform the AND logic 
operation. G6PDH (10 U·mL–1) and Glc6P (4 mM) were added to the solution to perform the 
filter operation. Logic 0 and 1 levels of ALT (0.02 and 2 U·mL–1) and LDH (0.15  and 1 U·mL–1) 
input signals were selected in order to mimic meaningful circulating levels of these biomarkers 
under normal and pathophysiological conditions, respectively. The output signal corresponding 
to the decreasing concentration of NADH was measured optically at  = 340 nm and defined as 
the absolute value of the absorbance change.  
 
 
RESULTS AND DISCUSSION 
 
The two enzyme inputs, ALT and LDH, are biomarkers characteristic of liver injury (LI).31 It 
should be noted that each of them is not specific enough to indicate LI, however their 
simultaneous increase in concentration, from normal to pathophysiological levels, provides an 
unambiguous evidence of LI.21,23 Based on the sequence of the biochemical reactions (Scheme 
1A), the final result — NADH oxidation followed by absorbance change (Figure 1A) — should 
happen only upon cooperative work of both enzyme-biomarkers. However, it should be 
remembered that logic-0 values in their present definition are not the absence of the enzymes, but 
rather their presence at normal physiological levels. Therefore, the reactions proceed not only at 
the 1,1 combination of the input signals, but also, albeit at slower rates, when the inputs are 
supplied at the 0,0, 0,1 and 1,0 combinations.  
 
When the readout time interval is limited to 50-200 sec, the absorbance decrease is sufficiently 
larger for the 1,1 input combination (implying output signal 1) as compared to three other input 
combinations that yield smaller absorbance changes (output signals 0) (Figure 1A). However, 
when the experiment continues to times larger than 200 sec, which is important for certain 
recently investigated actuation applications,32 the absorbance decrease for the 1,0 input 
combination becomes comparable with one for 1,1 inputs (Figure 1A). For even larger times, the 
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results for the 1,0 and 1,1 input combinations will not be distinguishable,  and the logic function 
can no longer be regarded as an AND gate (Figure 1B, Inset: black bars). In order to increase the 
gap separating 0 and 1 output signals, we have added a “filter” process30 consuming the chemical 
product NAD+ and converting it back to NADH for small input concentrations (Scheme 1). This 
has allowed us to achieve high-quality signal separation for times as large as 600 sec and 
beyond, as described below. 
 
We note that such processes can likely be implemented for any so-called NAD+-dependent 
dehydrogenase,33,34 e.g., glucose dehydrogenase activated by physiological amounts of glucose. 
However, aiming at the ultimate application of our system in physiological environment, we 
selected G6PDH, activated by Glc6P, which does not interfere with glucose naturally existing in 
blood. The filter system works in the following way: In the presence of G6PDH and Glc6P, the 
biocatalytically produced NAD+ is converted back to NADH, thus preventing the absorbance 
changes, until Glc6P is totally consumed, then NAD+ starts to accumulate resulting in the 
absorbance decrease. The delay in the biocatalytic formation of NAD+ is controlled by the 
amount of Glc6P added to the system and should be optimized. Comprehensive approach to the 
filter performance optimization could include detailed analysis of the reactions kinetics.30 
However, a simple experimental optimization applied in the present study might suffice. 
 
Application of the G6PDH-Glc6P filter following the biocatalytic cascade activated by ALT-
LDH biomarker inputs (Scheme 1), has allowed a much better separation of the output signals 
generated by the system for the 1,1 vs. all the other combinations of the inputs (Figure 1B). 
However, while improving the binary-signal separation, such filtering can decrease the overall 
signal strength which could be an added source of relative noise.28 Thus, this approach is useful 
for larger times when the  decrease in the absorbance reaches its saturation, of relevance in 
actuation applications.32 When the output signals were measured at 600 sec, the desired system 
operation corresponding to high-tolerance AND-logic realization was obtained in the presence of 
the filter (Figure 1B, Inset: red bars). Good-quality separation of the 0 and 1 output signals was 
found to persist at much larger times as well, up to 3 hours. The robustness of this analytical 
system has allowed its practical use in human serum solutions (see Supporting Information). 
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Receiver operating characteristic (ROC) analysis35 was used to evaluate the performance of the 
LI diagnostic test with and without the added signal filtering process (see Supporting 
Information for details). The levels of biomarkers were chosen according to the published 
physiological and pathophysiological concentrations relevant for the diagnosis of the liver 
injury.31 The present ROC analysis assesses the diagnostic properties due only to the analytical 
variance. Signal distributions in real medical-application situations can be different: additional 
comments on the “digital,” binary, and analog-to-digital conversion nature of the information 
processing here are offered in the Supporting Information. The reaction time at which signal 
values were measured was 600 sec. The area under the ROC curve (AUC) is a single measure 
summarizing the overall accuracy of a test. It represents the probability that the diagnostic test 
will correctly distinguish between the physiological and the pathophysiological samples.35 The 
AUC from empirical and smooth ROC curves,36 which expectedly give consistent results in this 
case (and the corresponding 95% confidence intervals; CI) were estimated for LI diagnostic 
system. The AUC without a filter, from the empirical ROC curve was 0.92 (95% CI: 0.79-1.00), 
and 0.90 (95% CI: 0.77-1.00) from the smooth ROC curve (Figure 2). On the other hand, the 
diagnostic system with enabled filter has no overlap between output signal values 0 and 1, i.e., of 
the ability to determine the output signals 0 and 1, it offers the so-called “perfect performance”35 
(of course, only as far as analytical-procedure variance goes) of a diagnostic test. The ROC curve 
has AUC of 1.00 (95% CI: 1.00-1.00), a result corresponding to 100% sensitivity and 100% 
specificity. For details see Supporting Information, where similar results of ROC analysis are 
presented demonstrating an improved operation of the STI and ABT systems with the new filter 
process. 
 
 
CONCLUSIONS 
 
Analytical systems performing binary AND logic operations for the analysis of biomarkers 
characteristic of LI, STI and ABT were improved by integrating them with the filter process 
which converts the output signal back to the original chemical up to the certain optimized extend. 
The usefulness of the added filtering for a reliable operation of “digital-logic” biochemical 
analytical systems was established. The next step in the development of complex information 
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and signal processing systems for analysis of injury biomarkers will involve analysis of samples 
from injured animals and human patients. This work is currently in progress and will be reported 
elsewhere. 
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SCHEME AND FIGURE CAPTIONS 
 
Scheme 1. The biocatalytic cascade operating as AND logic gate for analysis of LI, (A) without, 
and (B) with the added biocatalytic-filter reaction. The following abreviations for products 
and intermediates are used: Pyr for pyruvate, Lac for lactate, Glu for glutamate and 6-
PGluc for 6-phospho-gluconic acid. Other chemicals and the operation of the system are 
detailed in the Experimental section. 
 
Figure 1. Time dependent absorbance changes generated by the system outlined in Scheme 1, 
(A) without, and (B) with the added biocatalytic-filter reaction upon application of various 
combinations of the ALT and LDH input signals. The Inset shows the output signals 
measured at 600 sec, obtained without and with the filter process, for different 
combinations of the inputs. The vertical axis in the inset gives the normalized values of the 
averaged absorbance decrease, ∆An = ∆A / ∆Amax , ranging between 0 and 1, where Amax 
is the experimental mean value for the logic 1 output (the error bars shown are also 
normalized).  
 
Figure 2. Receiver operating characteristic (ROC) empirical (green) and smoothed (blue) curves 
for the non-filtered system for the LI. The two (coinciding) ROC curves for the filtered 
system are shown in red. Random choice is denoted by the gray diagonal line; the best 
cutoffs for calculating the maximized-accuracy detection are indicated as the color-coded 
symbols (for details see Supporting Information). 
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Supporting Information 
Summary of experimental results and their statistical treatment for the STI 
and ABT systems operating in buffer solutions and for the LI system 
operating in human serum solution 
 
Experimental Section 
 
Chemicals and materials: Alanine transaminase from porcine heart (ALT, E.C. 2.6.1.2), glucose-
6-phosphate dehydrogenase from Leuconostoc mesenteroides (G6PDH, E.C. 1.1.1.49), 
microperoxidase-11 (MP-11), lactate dehydrogenase from porcine heart (LDH, E.C. 1.1.1.27), 
pyruvate kinase from rabbit muscle (PK, E.C. 2.7.1.40), creatine kinase from rabbit muscle (CK, 
E.C. 2.7.3.2), glycyl-glycine (Gly-Gly), tris(hydroxymethyl) aminomethane hydrochloride (Tris-
buffer), L-alanine (Ala), α-ketoglutaric acid (α-KTG), β-nicotinamide adenine dinucleotide 
reduced dipotassium salt (NADH), β-nicotinamide adenine dinucleotide dipotassium salt 
(NAD+), L(+)-lactic acid (Lac), D-glucose 6-phosphate sodium salt (Glc6P), creatine anhydrous 
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(Crt), phospho(enol)pyruvate monopotassium salt (PEP), adenosine 5'-triphosphate disodium salt 
(ATP, from bacterial source), magnesium acetate tetrahydrate (MgAc2), potassium hydroxide 
(KOH), hydrochloric acid (HCl) and serum from human male AB plasma were purchased from 
Sigma-Aldrich and were used as supplied without further purification or pretreatment. Hydrogen 
peroxide (H2O2) (30% w/w) was purchased from Baker. Ultrapure deionized water 
(18.2 MΩ·cm) from a NANOpure Diamond (Barnstead) source was used in all of the 
experiments. 
 
Instrumentation and measurements: In order to mimic physiological conditions, optical 
measurements were done in temperature-controlled 1 mL poly(methyl methacrylate) (PMMA) 
cuvettes at 37.0 ± 0.2˚C with 1 cm pathway using Shimadzu UV-2450 UV-Vis 
spectrophotometer (with a TCC-240A temperature-controlled holder). All reagents were 
incubated at this temperature prior to experimentation. A Mettler Toledo SevenEasy s20 
pH-meter was employed for the pH measurements.  
 
Composition and operation of systems for the analysis of injuries 
 
LI system (serum experiment): Human serum was diluted to 50% by the Tris-buffer, pH 7.4. The 
final concentrations of the logic system “machinery” and components of the filter were Ala (200 
mM), α-KTG (10 mM), NADH (150 µM), Glc6P (4 mM) and G6PDH (10 U·mL-1). ALT and 
LDH used as biomarkers of liver injury were dissolved in pure human serum. Because of 
dilution, logic 0 and 1 levels of ALT (0.01 U·mL–1 and 1 U·mL–1) and LDH (0.075 and 0.5 
U·mL–1) were used as half of the physiological and pathophysiological values.1 Input signals 
were applied to the logic system in order to realize meaningful circulating levels of these 
biomarkers and perform the AND logic operation with filter. The output signal corresponding to 
the decreasing concentration of NADH was measured optically at λ = 340 nm.  
 
STI system (buffer experiment): Gly-Gly buffer, 50 mM, with MgAc2 (6.7 mM) was titrated with 
KOH to the pH value of 7.95 and used as a background solution (note that Mg2+ and K+ cations 
are essential for activation of CK and PK, respectively). The following components were 
dissolved in this solution to perform the AND logic operation: NADH (0.1 mM), ATP (1 mM), 
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PEP (1.5 mM), PK (1.6 U·mL–1), Crt (7.5 mM). The filtering compounds Glc6P (0.1 mM) and 
G6PDH (2 U·mL–1) were prepared in the same buffer. Logic 0 and 1 levels of CK (0.1 and 
0.71 U·mL–1) and LDH (0.15 and 1 U·mL–1) input signals were applied to the logic system in 
order to realize meaningful circulating levels of these biomarkers.2,3 The output signal 
corresponding to the decreasing concentration of NADH was measured optically at λ= 340 nm.  
 
ABT system (buffer experiment): Gly-Gly buffer, 50 mM, pH 8.5 tuned by KOH, containing 
MgAc2 (6.7 mM) and NAD+ (10 mM) was used to perform the AND logic operation. MP-11 
(50 µM) and H2O2 (1.5 mM) were used as filter components. Logic 0 and 1 levels of LDH (0.15 
and 1.0 U·mL–1) and Lac (1.6 and 6.0 mM) input signals were applied to the logic system in 
order to realize meaningful circulating levels of these biomarkers.3,4 The output signal 
corresponding to the NADH formation was measured optically at  = 340 nm.  
 
 
 
Figure SI 1. The biocatalytic cascade operating as the AND logic gate for analysis of the 
STI without (A) and with presence (B) of the biocatalytic filter. The following 
abreviations for products and intermediates are used: CrtP = phosphocreatine, ADP = 
adenosine diphosphosphate, Pyr = pyruvate, 6-PGluc = 6-phospho-gluconic acid. Other 
abbreviations are specified in the Chemicals and materials section. 
 
Results for the STI and ABT detection systems measured in buffer solutions and for the LI 
system measured in human serum solutions 
 
Soft Tissue Injury (STI) system operating in buffer: Two enzymes, CK and LDH, were applied as 
biomarkers characteristic of soft tissue injury.2,3 Their simultaneous increase from normal to 
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pathophysiological concentrations provides an evidence of STI conditions. The biochemical 
cascade catalyzed in the presence of the both enzyme-biomarkers (note the biocatalytic operation 
of PK being a part of the logic gate “machinery”) results in the oxidation of NADH to NAD+ 
(Figure SI 1A), thus yielding the corresponding absorbance decrease. The absolute value of the 
absorbance change was used to define the output signal produced by the system. The logic value 
of the output signal changes from the low 0 value to the high 1 value only upon the concerted 
work of the both enzyme-inputs (logic inputs combination 1,1), thus mimicking the AND logic 
operation. Since the logic 0 values of the input signals are not physical zero concentrations (they 
rather correspond to the normal physiological concentrations of the enzymes), the NADH 
absorbance is also changing upon other combinations of the inputs (0,0; 0,1; 1,0). Similarly to 
the LI system described in the main text of the paper, the STI system operation was improved 
upon addition of the filter system to the analyzing biocatalytic cascade (Figure SI 1). The 
experimental data obtained in the presence and absence of the filter are summarized in 
Figure SI 2 and statistically analyzed in Figure SI 3, as further detailed below. 
 
 
Figure SI 2.   Bar chart featuring the AND logic operation of the optical system for 
detection of the STI. The black-colored bars indicate performance of the STI system 
without filter whereas the red-colored bars are with the applied filter. Optical absorbance 
measurements were performed at  = 340 nm at time of 350 sec. 
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Figure SI 3.  Receiver operating characteristic (ROC) empirical (green line) and 
smoothed (blue line) curve for the non-filtered system in detection of the STI. ROC 
curves for the filtered system are shown in red color. Note the both empirical and smooth 
ROC curves for the filtered system correspond to the “perfect performance.” Random 
choice is denoted by the solid diagonal line. The best cutoffs which maximize the 
accuracy are indicated as solid symbols. 
 
 
Abdominal Trauma (ABT) system operating in buffer: The enzyme LDH and its substrate Lac 
appearing together at elevated concentrations can be used as biomarkers of ABT.3,4 The 
biocatalytic reaction activated by the enzyme and the corresponding substrate, results in the 
reduction of NAD+ cofactor (Figure SI 4), thus leading to increased absorbance at  = 340 nm 
corresponding to the formation of NADH. The absorbance change was defined as the output 
signal produced by the system. The logic value of the output signal changes from the low 0 value 
to the high 1 value only upon the concerted work of both inputs (logic inputs combination 1,1), 
thus mimicking AND logic operation. Since the logic 0 values of the input signals are not 
physical zero concentrations (they correspond to the normal physiological concentrations of the 
enzyme and its substrate), the NADH absorbance is also changing upon other combinations of 
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the inputs (0,0; 0,1; 1,0). Similarly to the LI system described in the main text of the paper, the 
ABT system operation was improved upon addition of the filter process to the analyzing 
biocatalytic cascade (Figure SI 4). The experimental data obtained in the presence and absence 
of the filter are summarized in Figure SI 5 and statistically analyzed in Figure SI 6. 
 
 
Figure SI 4. The biocatalytic cascade operating as an AND logic gate for analysis of the 
ABT in the absence (A) and in the presence (B) of the biocatalytic filter. The following 
abreviation for a product is used: Pyr = pyruvate. Other abbreviations are specified in the 
Chemicals and materials section. 
 
 
Figure SI 5. Bar chart featuring the AND logic operation of the optical system for 
detection of ABT. The corresponding combinations of input signals without a filter (the 
black bars) and with a filter (the red bars) are indicated. Optical absorbance 
measurements were performed at  = 340 nm at time of 1200 sec. 
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Figure SI 6. Receiver operating characteristic (ROC) empirical (green line) and 
smoothed (blue line) curve for non-filtered system in detection of the ABT. ROC curves 
for filtered system are shown in red color. Note the both empirical and smooth ROC 
curves for filtered system correspond to the “perfect performance.” Random choice is 
denoted by the grey diagonal line. The best cutoffs which maximize the accuracy are 
indicated as solid symbols. 
  
 
Liver Injury (LI) system operating in serum: The system is the same as described in the main part 
of the paper (Scheme 1; Figure SI 7), but its operation was studied in the presence of human 
serum solution. The experimental data obtained in the presence and absence of the filter are 
summarized in Figure SI 8 and statistically analyzed in Figure SI 9. 
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Figure SI 7 (the same as Scheme 1 in the paper). The biocatalytic cascade operating as 
the AND logic gate for analysis of LI in the absence (A) and in the presence (B) of the 
biocatalytic filter. The following abreviation for a product is used: 6-PGluc = 6-phospho-
gluconic acid, Pyr = pyruvate, Lac = lactate, Glu = glutamate. Other abbreviations are 
specified in the Chemicals and materials section. 
 
 
 
Figure SI 8. Bar charts featuring the AND logic operation of the optical system for 
detection of LI.  The corresponding combinations of input signals without a filter (the 
black bars) and with a filter (the red bars) are indicated.  
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Figure SI 9. Receiver operating characteristic (ROC) empirical (green line) and 
smoothed (blue line) curve for non-filtered system in detection of LI in serum. ROC 
curves for filtered system are shown in red color. Note the both empirical and smooth 
ROC curves for filtered system correspond to the “perfect performance.” Random choice 
is denoted by the grey diagonal line. The best cutoffs which maximize the accuracy are 
indicated as solid symbols.  
 
Statistical data analysis 
 
The biochemical cascade composed of the specific biocatalytic reactions, results in a distinct 
change in the output signal (change in absorbance) only in case of the cooperative action of both 
biomarkers (logic input combination 1,1) and logic value of the output attains 1. Other 
combinations of the input signals (0,0, 0,1 and 1,0) represent logic value of the output 0, but this 
occurs for non-zero physical values of the inputs, due to their physiological nature. The effect of 
the enzyme filter on improving the discrimination of logic output 0 and 1 was evaluated by 
Receiver Operating Characteristic (ROC) curves.  
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The accuracy of the diagnostic method depends on the ability to distinguish between 
pathophysiological and physiological samples being tested, which represent the logic output 1 
and 0, respectively. The “area under curve” (AUC) is a summary single measure, defined as an 
area under an ROC curve, which combines concepts of sensitivity and specificity and is 
commonly used for quantification of diagnostic test accuracy. The sensitivity—the “true positive 
rate” (TPR), and specificity—the “true negative rate” (TNR), both depend on the tested 
thresholds; the TPR and TNR vary as the threshold varies. By considering various possible 
values of the threshold, an ROC curve can be constructed as a continuous function of sensitivity 
versus specificity (possibly 1-specificity—the “false positive rate”; FPR).5 AUC of 1 represents  
“perfect performance,” i.e. 100% TPR, at TNR of 100%; AUC of 0.5 represents a random 
diagnosis.  
 
The AUCs of empirical ROC curves were estimated by the trapezoidal method of integration, 
and the corresponding 95% confidence intervals (CI) were estimated with the method described 
by De Long et al.6 Using the ROC analysis, the best thresholds (above which the absorbance 
change is considered as a logic output 1) that yielded the maximum accuracy were determined 
and characterized by their specificity and sensitivity with the corresponding 95% CIs. Smoothed 
ROC curves were additionally estimated by using a non-parametric method. The Kernel density 
function5 was used to fit smooth ROC curves to data points because this method is free of 
parametric assumptions.7 This smoothed-curve method outperforms the competing methods 
when pathophysiological and/or control group has a bimodal distribution (see the differences in 
absorbance changes between logic inputs 0,0, 0,1 and logic input 1,0). The bandwidth of the 
Kernel function is fixed using the robust method developed by Sheather and Jones.8 The AUCs 
of smooth ROC curves are indicated with corresponding 95% CIs computed with 2000 stratified 
bootstrap replicates as described elsewhere.9 All statistic tests and data plotting were performed 
using the standard R-project software R 2.1, available online10. 
  
Three enzymatic systems described above were evaluated by ROC curve analysis before and 
after the enzymatic filter was included. The cutoff values, sensitivity, specificity, and area under 
the empirical and smooth ROC curve for all the enzymatic systems without and with filter are 
presented in Table 1. In non-filtered enzymatic systems, the ability of the systems to distinguish 
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the logic output 0 from 1 was found as follows: (i) liver injury measured in serum (AUC 0.82, 
95% CI 0.55-1.00), (ii) soft tissue injury measured in buffer (AUC 0.91, 95% CI 0.76-1.00), and 
(iii) abdominal trauma measured in buffer (AUC 0.97, 95% CI 0.91-1.00). The AUCs for smooth 
ROC curves for non-filtered enzymatic systems were as follows: (i) liver injury measured in 
serum (AUC 0.83, 95% CI 0.65-1.00), (ii) soft tissue injury measured in buffer (AUC 0.80, 95% 
CI 0.73-0.95) and (iii) abdominal trauma measured in buffer (AUC 0.94, 95% CI 0.87-1.00). 
Using the enzymatic filter, we have achieved “perfect performance” in terms of the AUC for 
both empirical and smooth ROC curve in all diagnostic systems. ROC curves showed a very 
good discrimination between logical output 0 and 1, with an AUC of 1.00 (95% CI 1.00-1.00) for 
all filtered systems; such values correspond with 100% sensitivity and 100% specificity. Notice 
that in the case of the “perfect performance” the AUCs of empirical and smooth ROCs curve are 
the same. 
 
 
Table 1: Receiver Operating Characteristic Curve Analysis of the enzymatic systems for 
diagnosis of liver injury (performed in buffer and serum), soft tissue injury and 
abdominal trauma with the enabled/disabled biocatalytic filter. 
 
  
AUC 
95% CI 
Cutoff 
Sensitivity 
95% CI 
Specificity 
95% CI 
AUC (smooth ROC 
curve) 95% CI 
LI 
(Buffer) 
No Filter 0.92 (0.79-1.00) 1.70 0.60 (0.23-0.88) 1.00 (0.80-1.00) 0.90 (0.77-1.00) 
 
Filter 1.00 (1.00-1.00) 0.84 1.00 (1.00-1.00) 1.00 (1.00-1.00) 1.00 (1.00-1.00) 
LI 
(Serum) 
No Filter 0.82 (0.55-1.00) 0.77 0.67 (0.21-0.94) 0.89 (0.57-0.98) 0.83 (0.65-1.00) 
 
Filter 1.00 (1.00-1.00) 0.35 1.00 (1.00-1.00) 1.00 (1.00-1.00) 1.00 (1.00-1.00) 
STI 
(Buffer)  
No Filter 0.91 (0.76-1.00) 0.58 0.86 (0.49-0.97) 0.91 (0.62-0.98) 0.80 (0.73-0.95) 
 
Filter 1.00 (1.00-1.00) 0.47 1.00 (1.00-1.00) 1.00 (1.00-1.00) 1.00 (1.00-1.00) 
ABT 
(Buffer) 
No filter 0.97 (0.91-1.00) 0.76 1.00 (0.57-1.00) 0.93 (0.70-0.99) 0.94 (0.87-1.00) 
 
Filter 1.00 (1.00-1.00) 0.48 1.00 (1.00-1.00) 1.00 (1.00-1.00) 1.00 (1.00-1.00) 
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Finally, as stressed in the main text, we emphasize that, our conclusion of “perfect performance” 
applies only to the analytical variance of the process of the binary AND function generation and 
signal-conversion to digital answers. Indeed, we do not probe the additional noise effects due to 
actual clinical-testing concentration distributions of the biomarkers involved. The reason has 
been that the details of the latter distributions11,12 are simply not well known presently, even 
though all the considered biomarkers are used in actual biomedical testing, in different assay 
formats13,14 than those proposed here. As a precaution, we sat our 0 and 1 "digital"—perhaps 
more carefully termed "binary"—values safely at the edges of the approximately known2-4,15 
physiological and pathophysiological ranges: 0 approximately at the highest value of the lower 
range, 1 approximately at the lowest value of the upper range. In summary, our actual 
information processing thus involves the binary AND function accompanied by analog-to-digital 
signal conversion for the output, realized and made high-fidelity of adding the "filtering process" 
to the enzymatic reaction cascade. 
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